Charbonnel B, Chatal J F
Arch Mal Coeur Vaiss. 1986 Jun;79(6):980-4.
Ninety-nine patients suspected of having pheochromocytoma were studied with MIBG scintigraphy and in 92 of them were studied with computed tomography. In 49 patients, the diagnosis was ruled out, in 3 patients it remained doubtful, and in 47 patients it was confirmed. Two patients had epinephrine--and/or norepinephrine--non-secreting tumors and 45 had secreting pheochromocytomas. In these latter patients, there were 4 scintigraphic false-negatives, all intra-adrenal, and 4 computed tomography false-negatives, 3 extra-adrenal and 1 intra-adrenal. For about 80% of the patients and/or the tumor sites, both methods were thus in agreement. They were complementary in the remaining 20%. The advantage of scintigraphy is to screen the whole body with high specificity and to locate extra-adrenal sites or metastases of pheochromocytoma with better accuracy than computed tomography. The limits of scintigraphy are the possibility of false-negatives in around 10% of patients whereas computed tomography visualizes more than 95% of intra-adrenal tumors.
对99例疑似嗜铬细胞瘤的患者进行了间碘苄胍(MIBG)闪烁扫描检查,其中92例还进行了计算机断层扫描(CT)检查。49例患者排除了诊断,3例诊断仍存疑问,47例得到确诊。2例患者患有不分泌肾上腺素和/或去甲肾上腺素的肿瘤,45例患有分泌型嗜铬细胞瘤。在这些后者患者中,有4例假阴性闪烁扫描结果,均为肾上腺内肿瘤,4例假阴性CT结果,3例为肾上腺外肿瘤,1例为肾上腺内肿瘤。因此,对于约80%的患者和/或肿瘤部位,两种方法结果一致。在其余20%的情况下,它们具有互补性。闪烁扫描的优点是能以高特异性对全身进行筛查,并比CT更准确地定位嗜铬细胞瘤的肾上腺外部位或转移灶。闪烁扫描的局限性在于约10%的患者可能出现假阴性结果,而CT能显示超过95%的肾上腺内肿瘤。